Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.

Man LX, Statham MM, Rosen CA.

Ann Otol Rhinol Laryngol. 2010 Apr;119(4):236-8.

PMID:
20433022
2.

[Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].

Neumann K, Pudszuhn A, Welzel C, Bartel-Friedrich S, Passmann M.

Laryngorhinootologie. 2003 Oct;82(10):700-6. German.

PMID:
14593568
3.

Local and systemic effects of intralaryngeal injection of cidofovir in a canine model.

Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS, Shapiro NL.

Laryngoscope. 2003 Nov;113(11):1922-6.

PMID:
14603048
4.
5.

Cidofovir injection for recurrent laryngeal papillomatosis.

Shi ZP, Wang CH, Lee JC, Lin YS.

J Chin Med Assoc. 2008 Mar;71(3):143-6. doi: 10.1016/S1726-4901(08)70006-6.

6.

[Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].

Pontes P, Weckx LL, Pignatari SS, Fujita RR, Avelino MA, Sato J.

Rev Assoc Med Bras (1992). 2009 Sep-Oct;55(5):581-6. Portuguese.

7.

Novel method of intralesional cidofovir injection into laryngotracheal papillomata.

Sahota RS, Uddin FJ, Al-Shukri J, Moir AA.

J Laryngol Otol. 2011 Apr;125(4):402-4. doi: 10.1017/S0022215110003014. Epub 2011 Jan 31.

PMID:
21281536
8.

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L.

J Med Virol. 1998 Mar;54(3):219-25.

PMID:
9515772
9.

Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.

Shehab N, Sweet BV, Hogikyan ND.

Pharmacotherapy. 2005 Jul;25(7):977-89. Review.

10.
11.

Intralesional Cidofovir application in recurrent laryngeal papillomatosis.

Pudszuhn A, Welzel C, Bloching M, Neumann K.

Eur Arch Otorhinolaryngol. 2007 Jan;264(1):63-70. Epub 2006 Oct 13.

PMID:
17058091
12.

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.

Broekema FI, Dikkers FG.

Eur Arch Otorhinolaryngol. 2008 Aug;265(8):871-9. doi: 10.1007/s00405-008-0658-0. Epub 2008 May 6. Review.

13.
14.

Intralesional cidofovir for recurrent respiratory papillomatosis in children.

Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO.

Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1143-8.

PMID:
10522508
15.

Intralesional cidofovir and surgical excision for laryngeal papillomatosis.

Naiman AN, Ceruse P, Coulombeau B, Froehlich P.

Laryngoscope. 2003 Dec;113(12):2174-81.

PMID:
14660923
16.

Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.

Naiman AN, Abedipour D, Ayari S, Fresnel E, Coulombeau B, Bour JB, Froehlich P.

Ann Otol Rhinol Laryngol. 2006 Mar;115(3):175-81.

PMID:
16572605
17.

Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).

Tjon Pian Gi RE, Dietz A, Djukic V, Eckel HE, Friedrich G, Golusinski W, Hantzakos A, Lawson G, Remacle M, Rihkanen H, Dikkers FG.

Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2. doi: 10.1007/s00405-011-1804-7. Epub 2011 Oct 22. No abstract available.

18.

Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort.

Bielamowicz S, Villagomez V, Stager SV, Wilson WR.

Laryngoscope. 2002 Apr;112(4):696-9.

PMID:
12150526
19.

Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.

Mandell DL, Arjmand EM, Kay DJ, Casselbrant ML, Rosen CA.

Arch Otolaryngol Head Neck Surg. 2004 Nov;130(11):1319-23.

PMID:
15545589
20.

[Respiratory papillomatosis--new methods of treatment].

Nowaczewska K, Wójtowicz P, Kukwa A, Ratajczak J, Tulibacki M.

Otolaryngol Pol. 2010 Jan-Feb;64(1):31-6. doi: 10.1016/S0030-6657(10)70032-9. Polish.

PMID:
20476590

Supplemental Content

Support Center